Breaking News
December 10, 2018 - Scientists find answers to how cancer spreads
December 10, 2018 - Study explores why older people read more slowly
December 10, 2018 - Asbestos found in most NHS hospitals finds BBC inquiry
December 10, 2018 - Researchers use new technique to probe hydrogen bonds
December 10, 2018 - Music improves social communication in autistic children
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
Largest parasitic worm genetic study hatches novel treatment possibilities

Largest parasitic worm genetic study hatches novel treatment possibilities

image_pdfDownload PDFimage_print
Credit: CC0 Public Domain

The largest genomic study of parasitic worms to date has identified hundreds of thousands of new genes and predicted many new potential drug targets and drugs. The research from the Wellcome Sanger Institute, Washington University in St. Louis, the University of Edinburgh, and their collaborators will help scientists understand how these parasites invade us, evade the immune system and cause disease.

Reported in Nature Genetics today, the study could lead to new de-worming treatments to help prevent and treat the diseases caused by parasitic worms worldwide.

Parasitic worms cause some of the most neglected tropical diseases, including river blindness, schistosomiasis and hookworm disease, and blight the lives of over a billion people globally. Infections can last many years or even decades, leading to severe pain, massive physical disabilities, retarded development in children, and social stigma associated with deformity. Despite the huge health burden inflicted on many of the poorest countries of the world, there has been little investment in parasitic worm research.

To understand how worms can infest and live inside people, the researchers compared the genomes of 81 species of roundworms and flatworms, including 45 that had never been previously sequenced. Their analysis revealed almost a million new genes that had not been seen before, belonging to thousands of new gene families, and which had huge variations in how they were distributed between species.

The researchers found that some species of worms had enormous gene families to help them colonise the host gut, migrate through host tissue or digest food. Other species had many gene families that affect the host immune system to keep the worm hidden.

Dr. Matt Berriman, senior author from the Wellcome Sanger Institute, said: “Little is known about the biology of many parasitic worm species, so we used a broad comparison of their genomes to discover the most striking genetic differences between them. We have uncovered many new genes and gene families to help understand how the worms live and migrate inside us and other animals. This dataset will catapult worm research into a new era of discovery.”

Anti-worm treatments have remained unchanged for years and are often inadequate. In addition, an over-reliance on just a few existing drugs may lead to drug resistance. To search for new interventions, the researchers mined the dataset of 800,000 worm gene sequences to predict new worm drug targets and anti-worm drugs. Making use of the ChEMBL database* of existing drugs and chemicals, they narrowed the list down to 40 high-priority drug targets in the worms, and hundreds of possible existing drugs or compounds.

Dr. Avril Coghlan, lead analyst from the Wellcome Sanger Institute, said: “The spectrum of drugs available to treat worm infections is still very limited. We focussed our search by looking at existing drugs for human illnesses. This may provide a fast-track route to pinpointing existing drugs that could be repurposed for deworming.”

Further research could lead to a raft of new treatment possibilities to help improve the lives of the millions of people suffering from the neglected tropical diseases caused by these worms.

In addition to uncovering new genes and potential new deworming possibilities, the 81 genome sequences allow researchers to place each worm in the evolutionary tree of life, to help understand how parasites evolve.

Prof Mark Blaxter, an author from the University of Edinburgh, said: “All the parasites evolved from free living ancestors, and comparing their genomes has shown the changes that happen when a species becomes a parasite. Parasites affect most of the natural world, and these genomes hold a record of how these fascinating animals—and their astounding biology—came to be.”

The parasite genomes are also providing clues into how worms avoid being attacked by our immune systems. This could help our understanding of the immune system itself and ultimately let us use the natural power of the immune system to improve human health.

Associate Prof Makedonka Mitreva, senior author from Washington University’s McDonnell Genome Institute, said: “Parasitic worms are some of our oldest foes, and have evolved over millions of years to be expert manipulators of the human immune system. This study will lead to a better understanding of the biology of these important organisms, but could also help us better understand how our immune systems can be harnessed or controlled.”


Explore further:
Parasitic worm genome uncovers potential drug targets

More information:
Comparative genomics of the major parasitic worms, Nature Genetics (2018). DOI: 10.1038/s41588-018-0262-1

*ChEMBL is a database of bioactive molecules with drug-like properties, at the EMBL European Bioinformatics Institute.

Journal reference:
Nature Genetics

Provided by:
Wellcome Trust Sanger Institute

Tagged with:

About author

Related Articles